← Evidence map

ArticleHepatology international2014

Two-year results of a randomized, phase III comparative trial of telbivudine versus lamivudine in Chinese patients.

Ji-Dong Jia et al.PubMed ↗Publisher ↗

No numbers read from the abstract.

10 papers cite it

2013

2014

2015

2016

2017

2018

2019

2020

this paperpooled itcites it

Two-year results of a randomized, phase III comparative trial of telbivudine versus lamivudine in Chinese patients. | OpenQuestion